Watch HSCSW. Know when insiders buy.
One email the day a filing lands. Free.
HSCSW
HeartSciences Inc.
No price history available
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
63
WATCH · shorts 63
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM $5KNET INCOME −$10.3MNET CASH —52W —SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2027 · Jul 31 | $2K | +10.5% | 63.8% | −$2.9M | −$3.2M | — | -0.86 | −$1.3M | — | — | Sep 14 |
| Q4 2026 · Apr 30derived | $0 | −100.0% | — | −$2.5M | −$2.8M | — | -0.87 | −$1.7M | $0 | −$1.7M | Sep 14 |
| Q3 2026 · Jan 31 | $0 | — | — | −$1.9M | −$2M | — | -0.63 | −$1.5M | −$9K | −$1.5M | Mar 16 |
| Q2 2026 · Oct 31 | $2K | — | 58.3% | −$2.1M | −$2.4M | — | -0.85 | −$2.3M | — | — | Dec 15 |
| Q1 2026 · Jul 31 | $2K | — | 60.0% | −$1.9M | −$2.1M | — | -1.58 | −$2M | — | — | Sep 14 |
| Q4 2025 · Apr 30derived | $4K | — | 56.8% | −$1.9M | −$2.1M | — | -1.88 | −$1.6M | $0 | −$1.6M | Jul 23 |
| Q3 2025 · Jan 31 | $0 | −100.0% | — | −$2.4M | −$2.5M | — | -2.57 | −$1.6M | $0 | −$1.6M | Mar 16 |
| Q2 2025 · Oct 31 | — | — | — | −$2M | −$2.1M | — | -2.27 | −$2.2M | — | — | Dec 15 |
| Q1 2025 · Jul 31 | — | — | — | −$2.1M | −$2.1M | — | -2.64 | −$2M | — | — | Sep 11 |
| Q4 2024 · Apr 30derived | $0 | — | — | −$1.9M | −$1.8M | — | 0.11 | −$1.6M | $49K | −$1.6M | Jul 24 |
| Q3 2024 · Jan 31 | $15K | — | 69.0% | −$1.5M | −$1.6M | — | -3.01 | −$2.1M | $9K | −$2.1M | Mar 13 |
| Q2 2024 · Oct 31 | $4K | — | 61.0% | −$1.6M | −$1.7M | — | -15.92 | −$988K | $2K | −$990K | Dec 16 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Apr 30 | $4K | 59.1% | −$8.4M | −$9.1M | -211666.5% | -3.48 | −$7.4M | $4K | −$7.4M | — | — |
| FY2025 · to Apr 30 | $4K | 56.8% | −$8.4M | −$8.8M | -201499.5% | -9.34 | −$7.4M | $3K | −$7.4M | — | — |
| FY2024 · to Apr 30 | $19K | 67.3% | −$6.3M | −$6.6M | -35511.9% | -18.74 | −$6.1M | $64K | −$6.1M | — | — |
| FY2023 · to Apr 30 | $5K | 45.7% | −$6.1M | −$6.4M | -123384.3% | -80.00 | −$5.8M | $18K | −$5.8M | — | — |
| FY2022 · to Apr 30 | $14K | 45.1% | −$4.7M | −$4.8M | -33592.6% | -1.45 | −$3.6M | $2K | −$3.6M | — | — |
Every number comes from HeartSciences Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.